What is Mircera 30 µg/0.3 ml inj. sol. s.c./i.v. pre-filled syr. used for?

( ARTG ) MIRCERA is indicated for the treatment of anaemia associated with chronic kidney disease (CKD).

What pharmaceutical form is Mircera 30 µg/0.3 ml inj. sol. s.c./i.v. pre-filled syr. available in?

Mircera 30 µg/0.3 ml inj. sol. s.c./i.v. pre-filled syr.: Solution for injection (Intravenous use; Subcutaneous use)

What are the side effects of Mircera 30 µg/0.3 ml inj. sol. s.c./i.v. pre-filled syr.?

You can help ensure medicines are safe by reporting the side effects you experience. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Can Mircera 30 µg/0.3 ml inj. sol. s.c./i.v. pre-filled syr. be used during pregnancy?

( AHT ) For the active ingredient methoxy polyethylene glycol-epoetin beta You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What ATC class does Mircera 30 µg/0.3 ml inj. sol. s.c./i.v. pre-filled syr. belong to?

Mircera 30 µg/0.3 ml inj. sol. s.c./i.v. pre-filled syr.: ATC B03XA03 Methoxy Polyethylene Glycol-Epoetin Beta. ATC is the WHO Anatomical Therapeutic Chemical classification — it groups drugs by organ system and pharmacological mechanism.

OTC

Mircera 30 µg/0.3 ml inj. sol. s.c./i.v. pre-filled syr.

Solution for injection

INN: Epoetin-Beta-Methoxypolyethyleneglycol

Data updated: 2026-04-11

Available in:

🇩🇪🇬🇧🇯🇵🇹🇷

Form

Solution for injection

Dosage

—

Route

Intravenous use; Subcutaneous use

Storage

—

About This Product

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.